This inventor holds 1 USPTO granted patent. Top assignee: National University of Singapore. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Dyi Ni Charmian Cher: Innovator in Phospholipase Research
Introduction
Dyi Ni Charmian Cher is a prominent inventor based in Singapore, known for her significant contributions to the field of biochemistry. She has developed innovative solutions aimed at addressing critical health issues, particularly in the treatment and prevention of ischemia.
Latest Patents
Dyi Ni Charmian Cher holds 1 patent for her invention titled "Phospholipase(s) and use(s) thereof." This invention relates to phospholipase(s), isoforms, derivatives, mutants, and/or fragments thereof, which are utilized in the preparation of a medicament for the treatment and/or prevention of ischemia. The preferred application involves the use of secretory phospholipase, particularly phospholipase A, derived from snake venom.
Career Highlights
Dyi Ni Charmian Cher is affiliated with the National University of Singapore, where she conducts her research and development activities. Her work has garnered attention for its potential impact on medical treatments and therapies.
Collaborations
Dyi Ni collaborates with esteemed colleagues, including Kandiah Jeyaseelan and Arunmozhiarasi Armugam, who contribute to her research endeavors.
Conclusion
Dyi Ni Charmian Cher exemplifies the spirit of innovation in the field of biochemistry, with her groundbreaking work on phospholipases paving the way for advancements in medical treatments. Her contributions are vital in the ongoing quest to improve health outcomes for patients suffering from ischemia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile